SCHEMBL22062269

SCHEMBL22062269

CCOC(=O)C(=N)c1ccc2ccccc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.49
CES1 P23141 1/20 0.49
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 1/20 0.48
P2RY12 Q9H244 1/20 0.47
GAA P10253 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
PTPN1 P18031 1/20 0.46
F2 P00734 1/20 0.46
PLG P00747 1/20 0.46
PLAU P00749 1/20 0.46
KLKB1 P03952 1/20 0.46
KLK1 P06870 1/20 0.46
PRSS1 P07477 1/20 0.46
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2705465 0.84 CES2 (0.61) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL19309856 0.82 CES2 (0.53) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL9165319 0.82 ALDH1A1 (0.49) SMN1; SMN2ALDH1A1F2CA12CA1
SCHEMBL30278793 0.82 F2 (0.53) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL8205322 0.82 F2 (0.53) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL4866982 0.81 ALDH1A1 (0.50) CES2CES1NPC1RAB9ASMN1; SMN2
Hydrochloric Acid SCHEMBL14118767 0.80 F2 (0.52) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL30684671 0.80 CA12 (0.59) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL571295 0.80 CA12 (0.59) CES2CES1NPC1RAB9ASMN1; SMN2
SCHEMBL19333083 0.80 ALDH1A1 (0.59) NPC1RAB9ASMN1; SMN2ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10676427-B2 Diazomethylation reagent and process for using it FUNDACIÓ INSTITUT CATALÀ D'INVESTIGACIÓ QUÍMICA (ICIQ) (ES) 2020-06-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10676427-B2 Diazomethylation reagent and process for using it DDT, DDC, CYP2E1 CES2 99/4885CES1 516/4885NPC1 2902/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.